IRIS
MAFFIOLI, PAMELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.678
AS - Asia 7.563
EU - Europa 5.390
SA - Sud America 1.164
AF - Africa 269
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.457
CN - Cina 3.901
SG - Singapore 1.626
IE - Irlanda 1.180
UA - Ucraina 934
BR - Brasile 884
DE - Germania 766
HK - Hong Kong 752
FI - Finlandia 676
VN - Vietnam 588
RU - Federazione Russa 520
FR - Francia 331
IT - Italia 304
SE - Svezia 270
GB - Regno Unito 222
ZA - Sudafrica 157
IN - India 138
CA - Canada 132
AR - Argentina 97
BD - Bangladesh 88
IQ - Iraq 56
EC - Ecuador 54
MX - Messico 54
TR - Turchia 52
JP - Giappone 50
ID - Indonesia 42
CO - Colombia 36
NL - Olanda 36
PK - Pakistan 34
UZ - Uzbekistan 28
ES - Italia 25
PH - Filippine 25
VE - Venezuela 24
PL - Polonia 22
MA - Marocco 21
JO - Giordania 20
MY - Malesia 20
PE - Perù 19
TN - Tunisia 18
IR - Iran 17
CL - Cile 16
EG - Egitto 16
PY - Paraguay 16
SA - Arabia Saudita 16
AL - Albania 13
IL - Israele 13
TH - Thailandia 12
BE - Belgio 11
KE - Kenya 11
AT - Austria 10
KZ - Kazakistan 10
AU - Australia 9
BH - Bahrain 9
BO - Bolivia 9
MU - Mauritius 9
RO - Romania 9
AZ - Azerbaigian 8
DZ - Algeria 8
ET - Etiopia 8
NZ - Nuova Zelanda 8
PA - Panama 8
JM - Giamaica 7
KR - Corea 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
HU - Ungheria 6
NP - Nepal 6
AM - Armenia 5
CH - Svizzera 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
LT - Lituania 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
EE - Estonia 4
GR - Grecia 4
LV - Lettonia 4
MD - Moldavia 4
OM - Oman 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GE - Georgia 3
HN - Honduras 3
KW - Kuwait 3
LB - Libano 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SN - Senegal 2
TW - Taiwan 2
Totale 23.057
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.326
Dublin 1.180
Chandler 1.053
Nanjing 1.001
Singapore 784
San Jose 760
Hong Kong 736
Dallas 691
Ashburn 622
Boardman 430
Nanchang 421
Beijing 350
Shenyang 300
Hebei 283
Princeton 283
Lawrence 275
Medford 267
Lauterbourg 266
Changsha 257
Wilmington 253
Jiaxing 221
Ho Chi Minh City 213
Los Angeles 206
Munich 174
Hangzhou 171
Helsinki 156
Tianjin 149
Hanoi 139
Johannesburg 136
Redondo Beach 123
Buffalo 120
Moscow 93
São Paulo 87
Toronto 73
New York 58
Shanghai 58
Cambridge 55
Ann Arbor 53
Milan 51
Seattle 50
Woodbridge 49
Tokyo 46
Santa Clara 40
Fairfield 33
Norwalk 33
Orem 33
Turku 31
Da Nang 29
Jinan 29
Montreal 28
Des Moines 27
Rio de Janeiro 27
Tashkent 26
Baghdad 25
Chennai 25
Frankfurt am Main 25
Quito 25
San Francisco 24
Brooklyn 23
Guangzhou 23
Haiphong 23
Kunming 23
Zhengzhou 21
Bruino 19
Dhaka 19
Pavia 19
Stockholm 19
Belo Horizonte 18
Campinas 18
Chicago 18
London 18
Amman 17
Genova 17
Pune 17
Boston 16
The Dalles 16
Curitiba 15
Guayaquil 15
Ankara 14
Lima 14
Phoenix 14
Warsaw 14
Bologna 13
Falkenstein 13
Ningbo 13
Orange 13
Piscataway 13
Salvador 13
Bogotá 12
Charlotte 12
Hải Dương 12
Lahore 12
Biên Hòa 11
Brasília 10
Cairo 10
Guarulhos 10
Mexico City 10
Quận Bình Thạnh 10
Thái Bình 10
Tirana 10
Totale 15.116
Salva come PNG Salva come JPEG
Nome #
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial 242
A randomized, placebo-controlled study about the effect of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters 198
Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial 182
A possible way to improve the glycemic control and the beta cell function during three years: the triple therapy. 154
A multicenter, randomised, single-blind study on the effects of exenatide or glimepiride on insulin resistance. 150
A comparison between sitagliptin or glibenclamide in addition to metformin+pioglitazone on glycemic control and beta-cell function: the triple oral therapy 142
Abscisic Acid Treatment in Patients with Prediabetes. 139
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus 130
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients 129
Different actions of losartan and ramipril on adipose tissue Activity and vascular remodeling biomarkers in hypertensive patients 129
Adipocytokines levels in obese and non-obese subjects, an observational study 129
Effetti sulla variabilità glicemica e sul compenso glico-metabolico di metformina, pioglitazone e sitagliptin in pazienti affetti da diabete mellito di tipo 2 128
Diagnostico y Tratamiento de los desordenes lipidicos. Mc Graw Hill Education 2014. 127
A systematic reviewandmeta-analysis of randomized controlled trials investigating the effects of supplementationwith Nigella sativa (black seed) on blood pressure 127
A randomized, double blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. 126
A randomized, double blind, comparative therapy evaluating sitagliptin versus glibenclamide in type 2 diabetic patients already treated with pioglitazone and metformin: a three years study 126
Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study 125
Diarrea in paziente diabetico 123
Confronto tra candesartan e olmesartan sui parametri correlati alla sensibilità insulinica nei pazienti ipertesi con diabete mellito di tipo 2 122
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load 120
Differential effect of candesartan and olmesartan on adipose tissue activity biomarkers in type 2 diabetic hypertensive patients 119
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients 117
A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients 116
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia 115
Acarbose compared to placebo on insulin resistance biomarkers in a double-blind, placebo-controlled trial 115
Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients 114
A curious case of hypoglycaemia 112
Effects of berberis aristata/silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients 112
A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk 112
Comparison between exenatide and glimepiride on metabolic control and on insulin resistance in type 2 diabetic patients with metformin therapy 110
Different aspects of sartan + calcium antagonist association compared to the single therapy on inflammation and metabolic parameters in hypertensive patients 110
Differenti effetti di candesartan e olmesartan sui parametri di attività del tessuto adiposo in pazienti diabetici di tipo 2 ipertesi 108
Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients 107
Effetti di un anno di trattamento con vildagliptin associato a pioglitazone o glimepiride in pazienti diabetici scarsamente controllati 107
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone 106
Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. 106
Effects of sibutramine plus L-carnitine compared to sibutramine on inflammatory parameters in type 2 diabetic patients 105
n-3 PUFAs on metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients after euglycemic clamp and oral fat load. 104
Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients 103
Effetti di un anno di trattamento con orlistat+L-carnitina paragonato a orlistat o placebo sui parametri di insulino-resistenza nei pazienti diabetici 103
Berberis aristata/silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients 103
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study 103
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus 102
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea. 100
Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis 100
Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; a double-blind, randomized, placebo-controlled trial 98
Effects of berberine on lipid profile in subjects with low cardiovascular risk 97
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation 96
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients 96
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin 95
Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy 95
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus 94
Berberis aristata/Silybum marianum fixed combination (Berberol®) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: A randomized, placebo-controlled, clinical trial. 93
Effect of manidipine-rosuvastatin combination on fibrinolysis, inflammation markers and insulin sensitivity in hypertensive hypercholesterolemic patients 92
Prevalence of erectile dysfunction in males affected by type 2 diabetes and the impact of hyperinsulinemia 91
Aerobic physical activity in obese subjects compared to anaerobic/aerobic physical activity 91
Hypoglycemia, its implications in the clinical practice, and possible ways to prevent it. 91
Prevalence and associations of erectile dysfunction in a sample of italian males with type 2 diabetes. 91
A role for quercetin in coronavirus disease 2019 (COVID-19) 90
Candesartan effect on inflammation in hypertension 90
Valutazione dei livelli di metalloproteasi 2 e 9 e dei loro inibitori nei soggetti con dislipidemia combinata 90
Sitagliptin added to previously taken anti-diabetic agents on insulin resistance and lipid profile: a two years study evaluation. 90
Canrenone on cardiovascular mortality in congestive heart failure: CanrenOne eFFects on cardiovascular mortality in patiEnts with congEstIve hearT failure: The COFFEE-IT study 89
Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients 89
Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study 89
Effect of aliskiren addition to losartan on fibrinolysis in diabetic hypertensive patients: a three-way crossover study. 89
Vildagliptin added to metformin on β-cell function after an euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetic patients. 89
Effetti di un carico lipidico orale sui marcatori di rimodellamento vascolare nei soggetti sani 88
Effetto del telmisartan sui marcatori infiammatori a digiuno e postprandiale nei pazienti diabetici ipertesi 88
Sitagliptin in aggiunta alla precedente terapia ipoglicemizzante sull'insulino-resistenza e il profilo lipidico: uno studio a due anni 88
Valutazione dell’infiammazione e delle MMPs nei soggetti con e senza diabete durante OGTT 88
A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease 87
Current and emerging pharmacotherapies for the management of hypertension, focus on aliskiren 87
Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study 87
Effects of berberine on lipid profile in subjects with low cardiovascular risk 86
Effetti di sitagliptin o metformina associati a pioglitazone in pazienti diabetici scarsamente controllati 86
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus 86
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patients 86
Matrix metalloproteinase-2 and – 9 levels in obese patients 85
Effects of thiazolidinediones and sulfonylureas in patients with diabetes 85
Fenofibrate, simvastatin and their combination in the management of dyslipidaemia in type 2 diabetic patients 85
Anti-obesity drugs: a review about their effects and their safety 85
Treatment options for hypercholesterolemia and combined dyslipidemia: focus on pitavastatin 85
Effects on oral fat load of a nutraceutical combination of fermented red rice, sterol esters and stanols, curcumin, and olive polyphenols: A randomized, placebo controlled trial 85
Evaluation of candesartan compared to olmesartan on insulin sensitivity-related parameters in type 2 diabetic hypertensive patients 84
Effetti di un carico lipidico orale sui marcatori di infiammazione e stress endoteliale nei soggetti sani 84
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia during omega-3 polyunsaturated fatty acids therapy 84
Effetti di un anno di trattamento con exenatide paragonato a glibenclamide in pazienti diabetici di tipo 2 84
Metformina in bustine rispetto a metformina nella classica formulazione in compresse: primi risultati di uno studio clinico 84
Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus. 84
Berberine induced improvement in hepatic steatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals 84
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: A randomized, double-blind, placebo controlled study 84
Comparison of orlistat treatment and placebo in obese type 2 diabetic patients 83
Rosiglitazone maleate and glimepiride in fixed combination for the metabolic control of type 2 diabetes 83
Effetti della formulazione idrosolubile di metformina sul compenso glicemico e sulla qualità della vita in pazienti con diabete mellito di tipo 2 83
Effetti di sitagliptin rispetto a glibenclamide in aggiunta a metformina e pioglitazone in pazienti diabetici di tipo 2 83
Olmesartan/amlodipine combination vs olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients 83
Pharmacotherapy for Obesity 83
Effetti di una combinazione di un estratto di berberis aristata/silybum marianum sul profilo lipidico e la secrezione insulinica in pazienti dislipidemici 83
Impact of the glyco-metabolic control on erectile dysfunction in patients with type 2 diabetes mellitus 82
Totale 10.384
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 0 0 0 0 0 286 225 45
2021/20221.031 9 4 65 9 4 6 8 58 59 7 175 627
2022/20233.250 358 193 6 221 372 348 2 198 1.370 40 94 48
2023/20241.058 120 196 37 73 121 257 16 120 9 33 37 39
2024/20253.371 24 329 98 110 70 89 246 284 718 77 368 958
2025/20267.278 552 588 1.066 1.006 817 310 1.495 343 647 454 0 0
Totale 23.435